Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time? [electronic resource]

By:

Barroso-Sousa, Romualdo

Contributor(s):

Shapiro, Geoffrey I
Tolaney, Sara M

Publication details: Stem cell investigation 2019Description: 4 p. digitalISSN:

2306-9759

Online resources:

Available from publisher's website

In: Stem cell investigation vol. 6

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Editorial; Comment

There are no comments on this title.

Browse results Close

Back to results

21 Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.
by Henry, N L
22 Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age.
by Desta, Z
23 Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.
by Rae, J M
24 Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
by Hertz, D L
25 A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
by Rothenberg, M L
26 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
by Burris, H A
27 Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
by Henry, D H
28 Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
by Henry, N L

Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time?

APA

Barroso-Sousa R., Shapiro G. I. & Tolaney S. M. (2019). Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time?. : Stem cell investigation.

Chicago

Barroso-Sousa Romualdo, Shapiro Geoffrey I and Tolaney Sara M. 2019. Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time?. : Stem cell investigation.

Harvard

Barroso-Sousa R., Shapiro G. I. and Tolaney S. M. (2019). Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time?. : Stem cell investigation.

MLA

Barroso-Sousa Romualdo, Shapiro Geoffrey I and Tolaney Sara M. Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time?. : Stem cell investigation. 2019.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC